Gilead Sciences Inc · Resolved Sep 4, 2025
As of · Judge evaluation as of Aug 31, 2025
With the leveraged potential in the biotechnology sector and recent positive trends, GILD represents a solid buying opportunity.
Selling GILD based on deterioration in performance and potential to invest elsewhere.
△GPT-3.5 was right · −0.3% vs S&P 500
20 sessions from Aug 6, 2025 to Sep 4, 2025. The BUY side wins when the stock beats the index; the SELL side wins when it lags.
50 shares
With the leveraged potential in the biotechnology sector and recent positive trends, GILD represents a solid buying opportunity.
40 shares
Selling GILD based on deterioration in performance and potential to invest elsewhere.
Window: 20 trading sessions from the later decision (Aug 6, 2025). Returns are price returns against SPY (unadjusted). Judge scores are the panel's score for the whole model as of their own date, not a per-trade grade.
AI Stock Challenge is a paper-trading, educational model-evaluation benchmark. Nothing here is investment advice.